Zicort 6 Tablet contains Deflazacort 6 mg, a corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain dermatological disorders. Deflazacort exerts its therapeutic effect by modulating the immune response and reducing inflammation through inhibition of multiple inflammatory mediators. Zicort 6 is also utilized in the treatment of certain muscular dystrophies to improve muscle strength and function. The medication is administered orally and should be taken as prescribed by a healthcare professional, with dosage tailored according to the severity of the condition and patient response. Common side effects may include gastrointestinal disturbances, increased susceptibility to infections, mood changes, and alterations in glucose metabolism. Long-term use necessitates regular monitoring for potential adverse effects such as osteoporosis, adrenal suppression, and hypertension. Abrupt discontinuation should be avoided to prevent withdrawal symptoms; tapering under medical supervision is recommended. Zicort 6 is contraindicated in patients with systemic fungal infections and known hypersensitivity to deflazacort or corticosteroids. Caution is advised in patients with diabetes, hypertension, or peptic ulcer disease. Always consult a healthcare provider before initiating therapy.